Zevra Therapeutics, Inc. Public Float
Zevra Therapeutics, Inc. (ZVRA) had Public Float of $454.80 million as of 2025-06-30, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-09
- 2025-06-30: Entity Public Float $454.80M.
- 2024-06-30: Entity Public Float $204.80M.
- 2023-06-30: Entity Public Float $172.10M.
- 2022-06-30: Entity Public Float $152.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $454.80M 10-K · filed 2026-03-09 |
| 2024-06-30 | $204.80M 10-K · filed 2025-03-12 |
| 2023-06-30 | $172.10M 10-K · filed 2024-04-01 |
| 2022-06-30 | $152.90M 10-K · filed 2023-03-07 |
| 2021-06-30 | $446.20M 10-K · filed 2022-03-31 |
| 2020-06-30 | $18.50M 10-K · filed 2021-03-12 |
| 2019-06-28 | $38.66M 10-K · filed 2020-02-28 |
| 2018-06-30 | $71.92M 10-K · filed 2019-03-01 |
| 2017-06-30 | $46.54M 10-K · filed 2018-03-30 |
| 2016-06-30 | $46.41M 10-K · filed 2017-03-10 |
| 2015-06-30 | $206.97M 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |